ReviewBrain & spine2026
Health-related quality of life disparities among vestibular schwannoma patients under different treatment regimens: A systematic review and meta-analysis.
Review in Brain & spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Vestibular schwannomas (VS) may cause hearing loss, balance disturbances, facial nerve dysfunction, and other symptoms that substantially affect health-related quality of life (HRQoL). As multiple management strategies exist, understanding treatment-specific HRQoL outcomes is essential for patient-centered decision-making. Research question: How do treatment options differ with respect to patient-reported HRQoL outcomes in vestibular schwannoma? Material and methods: A systematic search identified cross-sectional studies assessing HRQoL using the Penn Acoustic Neuroma Quality of Life (PANQOL) questionnaire. Eleven studies including 5156 patients met inclusion criteria. Random-effects meta-analyses were conducted for total PANQOL scores and key subdomains. Standardized mean differences (Hedges' g) were calculated for pairwise treatment comparisons. Risk of bias was assessed using the Joanna Briggs Institute checklist. Results: Microsurgery was associated with a non-significant reduction in total PANQOL scores compared with radiotherapy (g = -0.43, p = 0.09) and a significant reduction compared with observation (g = -1.58, p = 0.01). No significant difference was observed between radiotherapy and observation (g = -0.34, p = 0.26). Subdomain analyses showed that microsurgery was negatively associated with facial function, balance, hearing, and pain, while anxiety, energy, and general health did not differ significantly between treatment options. Heterogeneity across analyses was substantial (I Discussion and conclusion: For small to medium-sized VS, radiotherapy and observation were generally associated with better HRQoL preservation than microsurgery, particularly in facial function and pain domains. Surgery remains necessary for large or symptomatic tumors. HRQoL outcomes should be integrated into shared decision-making to inform patients about domain-specific treatment trade-offs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.